Evidence-based diuretics: Focus on chlorthalidone and indapamide

Future Cardiology

Volumn 11, Issue 2, 2015, Pages 203-217

  Dinicolantonio, James J ^a   Bhutani, Jaikrit ^b   Lavie, Carl J ^c,d   O'Keefe, James H ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

chlorthalidone; hydrochlorothiazide; hypertension; indapamide; thiazide

Indexed keywords

CHLORTALIDONE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; HYPONATREMIA; META ANALYSIS (TOPIC); MONOTHERAPY; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC);

ANTIHYPERTENSIVE AGENTS; CHLORTHALIDONE; DIURETICS; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDAPAMIDE;

EID: 84924654685     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.14.83     Document Type: Review

References (100)

1. Rosamond W, Flegal K, Furie K., et al. Heart disease and stroke statistics -2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), e25-e146 (2008
2. Roush GC, Kaur R, Ernst ME. Diuretics: a review and update. J. Cardiovasc. Pharmacol. Ther. 19(1), 5-13 (2014
3. James PA, Oparil S, Carter BL., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5), 507-520 (2014
4. Dinicolantonio JJ. Hydrochlorothiazide: is it a wise choice?. Expert Opin. Pharmacother. 13(6), 807-814 (2012
5. Hackam DG, Quinn RR, Ravani P., et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can. J. Cardiol. 29(5), 528-542 (2013
6. NICE. Hypertension: the clinical management of primary hypertension in adults. CG127/NICE Guideline. National Clinical Guideline Centre. www.guidance.nice.org.uk/cg127
7. Capps J, Wiggins W, Axelrod D., et al. The effect of mercurial diuretics on the excretion of water. Circulation 6(1), 82-89 (1952
8. Novello FC, Sprague JM. Benzothiadiazine dioxides as novel diuretics. J. Am. Chem. Soc. 79(8), 2028-2029 (1957
9. Freis E, Wanko A, Wilson IM., et al. Treatment of essential hypertension with chlorothiazide (Diuril). JAMA 166(2), 137-140 (1958
10. Moser M, Macauley AI. Chlorothiazide as an adjunct in the treatment of essential hypertension. Am. J. Cardiol. 3(2), 214-219 (1959
11. Reilly RF, Ellison DH. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol. Rev. 80, 277-313 (2000
12. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure?. J. Renin Angiotensin Aldosterone Syst. 5(4), 155-160 (2004
13. Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst. Rev. (10), CD005185 (2011
14. Ernst ME, Carter BL, Goerdt CJ., et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47, 352-358 (2006
15. Allen JH, McKenney JM, Stratton MA., et al. Antihypertensive effect of hydrochlorthiazide administered once or twice daily. Clin. Pharm. 1, 239-243 (1982
16. Mironneau J, Savineau JP, Mironneau C. Compared effects of indapamide, hydrochlorothiazide and chlorthalidone on electrical and mechanical activities in vascular smooth muscle. Eur. J. Pharmacol. 75, 109-113 (1981
17. Cooper-DeHoff JD. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev. Cardiovasc. Ther. 8(6), 793-802 (2010
18. Madkour H, Gadallah M, Riveline B., et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am. J. Cardiol. 77, 23B-25B (1996
19. Carey PA, Sheridan DJ, De Cordoue A., et al. Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis. Am. J. Cardiol. 77, 17B-19B (1996
20. Emeriau JP, Knauf H, Pujadas JO., et al. A comparison of indapamide SR 1.5mg with both amlodipine 5mg and hydrochlorothiazide 25mg in elderly hypertensive patients: a randomized double-blind controlled study. J. Hypertens. 19(2), 343-350 (2001
21. Ernst ME, Neaton JD, Grimm RH Jr., et al. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 58(6), 1001-1007 (2011
22. Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension 56(3), 463-470 (2010
23. Mogensen CE, Viberti G, Halimi S., et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 41(5), 1063-1071 (2003
24. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N. Engl. J. Med. 361, 2153-2164 (2009
25. National Collaborating Centre for Chronic Conditions. Hypertension: Management in Adults in Primary Care: Pharmacological Update.Royal College of Physicians, London, UK (2006
26. Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff. Resour. Alloc. 4, 10 (2006
27. Callahan MA, Do HT, Caplan DW., et al. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad. Med. 121(2), 186-191 (2009
28. Shea AM, Hammill BG, Curtis LH., et al. Medical costs of abnormal serum sodium levels. J. Am. Soc. Nephrol. 19, 764-770 (2008
29. Zilberberg MD, Exuzides A, Spalding J., et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr. Med. Res. Opin. 24, 1601-1608 (2008
30. Leung AA, Wright A, Pazo V, Karson A, Bates DW. Risk of thiazide induced hyponatremia in patients with hypertension. Am. J. Med. 124(11), 1064-1072 (2011
31. Decaux G. Is asymptomatic hyponatremia really asymptomatic?. Am. J. Med. 119(7 Suppl. 1), S79-S82 (2006
32. GankamKengne F, Andres C, Sattar L., et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101(7), 583-588 (2008
33. Dhalla IA, Gomes T, Yao Z., et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann. Intern. Med. 158(6), 447-455 (2013
34. Chan TY. Indapamide-induced severe hyponatraemia and hypokalaemia. Ann. Pharmacother. 29(11), 1124-1128 (1995
35. Yong TY, Huang JE, Lau SY., et al. Severe hyponatremia and other electrolyte disturbances associated with indapamide. Curr. Drug Saf. 6(3), 134-137 (2011
36. Chapman MD, Hanrahan R, McEwen J., et al. Hyponatraemia and hypokalaemia due to indapamide. Med. J. Aust. 176(5), 219-221 (2002
37. Hoes AW, Grobbee DE, Lubsen J. Sudden cardiac death in patients with hypertension: an association with diuretics and beta-blockers?. Drug Saf. 16(4), 233-241 (1997
38. Cohen JD, Neaton JD, Prineas RJ., et al. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am. J. Cardiol. 60(7), 548-554 (1987
39. Cushman WC, Khatri I, Materson BJ., et al. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Arch. Intern. Med. 151(10), 1954-1960 (1991
40. Alderman MH, Piller LB, Ford CE., et al. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Hypertension 59(5), 926-933 (2012
41. Ernst ME, Carter BL, Zheng S., et al. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am. J. Hypertens. 23(4), 440-446 (2010
42. Plante GE, Robillard C. Indapamide in the treatment of essential arterial hypertension: results of a controlled study. Curr. Med. Res. Opin. 8(Suppl. 3), 59-66 (1983
43. Ambrosioni E, Safar M, Degaute JP., et al. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomized doubleblind controlled studies. European study group. J. Hypertens. 16(11), 1677-1684 (1998
44. Sica DA, Schoolwerth A. Renal handing of organic anions and cations and renal excretion of uric acid. In: The Kidney. Brenner B, Rector F (Eds). WB Saunders, PA, USA, 637-662 (2004
45. Dorsch MP, Gillespie BW, Erickson SR., et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 57(4), 689-694 (2011
46. Franse LV, Pahor M, Di Bari M., et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J. Hypertens. 18(8), 1149-1154 (2000
47. Myers MG, Asmar R, Leenen FH., et al. Fixed low-dose combination therapy in hypertension: a dose response study of perindopril and indapamide. J. Hypertens. 18(3), 317-325 (2000
48. Kreeft JH, Langlois S, Ogilvie RI. Comparative trial of indapamide and hydrochlorothiazide in essential hypertension with forearm plethysmography. J. Cardiovasc. Pharmacol. 6(4), 622-626 (1984
49. Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J. Clin. Pharmacol. 31(8), 751-757 (1991
50. Savage PJ, Pressel SL, Curb JD., et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch. Intern. Med. 158(7), 741-751 (1998
51. Zillich AJ, Garg J, Basu S., et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48(2), 219-224 (2006
52. Manrique C, Giles TD, Ferdinand KC., et al. Realities of newer β-blockers for the management of hypertension. J. Clin. Hypertens. (Greenwich) 11(7), 369-375 (2009
53. Stears AJ, Woods SH, Watts MM., et al. A double-blind, placebocontrolled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension. Hypertension 59(5), 934-942 (2012
54. Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH., et al. Drug induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf. 24(6), 443-456 (2001
55. Lakshman MR, Reda DJ, Materson BJ., et al. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch. Intern. Med. 159(6), 551-558 (1999
56. Kostis JB, Wilson AC, Freudenberger RS., et al. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am. J. Cardiol. 95(1), 29-35 (2005
57. Peer R, Black HR, Davis B., et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 31(2), 353-360 (2008
58. Ames RP. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am. J. Cardiol. 77(6), B12-B16 (1996
59. Puig JG, Marre M, Kokot F., et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with Type 2 diabetes. Am. J. Hypertens. 20(1), 90-97 (2007
60. Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies. Drug Saf. 24(15), 1155-1165 (2001
61. Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 59(6), 1110-1117 (2012
62. SHEP Cooperative Research Group. . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265(24), 3255-3264 (1991
63. Patel A, Macmahon S, Chalmers J., et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with Type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370(9590), 829-840 (2007
64. De Galan BE, Perkovic V, Ninomiya T., et al. Lowering blood pressure reduces renal events in Type 2 diabetes. J. Am. Soc. Nephrol. 20(4), 883-892 (2009
65. PROGRESS Collaborative Group. Randomised trial of a peridopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358(9287), 1033-1041 (2001
66. Beckett NS, Peters R, Fletcher AE., et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358(18), 1887-1898 (2008
67. PATS Collaborating Group. Post-stroke antihypertensive treatment study: a preliminary result. Chin. Med. J. (Engl.) 108(9), 710-717 (1995
68. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation 117(20), 2706-2715 (2008
69. Messerli FH, Makani H, Benjo A., et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J. Am. Coll. Cardiol. 57(5), 590-600 (2011
70. Materson BJ, Cushman WC, Goldstein G., et al. Treatment of hypertension in the elderly. I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative study. Hypertension 15(4), 348-360 (1990
71. Wing LM, Reid CM, Ryan P., et al. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl. J. Med. 348(7), 583-592 (2003
72. Jamerson K, Weber MA, Bakris GL., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 359(23), 2417-2428 (2008
73. Leren P, Helgeland A. Oslo hypertension study. Drugs 31(Suppl. 1), 41-45 (1986
74. The Management Committee. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1(8181), 1261-1267 (1980
75. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202(11), 1028-1034 (1967
76. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 213(7), 1143-1152 (1970
77. Amery A, Birkenhager W, Brixko P., et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1(8442), 1349-1354 (1985
78. O'Malley K, Cox JP, O'Brien E. Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension. Cardiovasc. Drugs Ther. 4(Suppl. 6), 1249-1251 (1991
79. Wilhelmsen L, Berglund G, Elmfeldt D., et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J. Hypertens. 5(5), 561-572 (1987
80. De Leeuw PW, Ruilope LM, Palmer CR., et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch. Intern. Med. 164(22), 2459-2464 (2004
81. Simon A, Gariepy J, Moyse D., et al. Differential effects of nifedipine and co-amilozide on the porgression of early carotid wall changes. Circulation 103(24), 2949-2954 (2001
82. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242(33), 2562-2571 (1979
83. The Multiple Risk Factor Intervention Trial Research Group. Mortality after 10' years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 82(5), 1616-1628 (1990
84. The Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priority hypotheses of the trial. JAMA 263(13), 1795-1801 (1990
85. Neaton JD, Grimm RH Jr, Prineas RJ., et al. Treatment of Mild Hypertension Study: final results. Treatment of Mild Hypertension Study Research Group. JAMA 270(6), 713-724 (1993
86. Zanchetti A, Rosei EA, Dal Palu C., et al. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J. Hypertens. 16(11), 1667-1676 (1998
87. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trail (ALLHAT). JAMA 288(23), 2981-2997 (2002
88. Gosse P, Sheridan DJ, Zannad F., et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J. Hypertens. 18(10), 1465-1475 (2000
89. Baguet JP, Robitail S, Boyer L., et al. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Am. J. Cardiovasc. Drugs 5(2), 131-140 (2005
90. London G, Schmieder R, Calvo C., et al. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am. J. Hypertens. 19(1), 113-121 (2006
91. Akram J, Sheikh UE, Mahmood M., et al. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study. Curr. Med. Res. Opin. 23(12), 2929-2936 (2007
92. Kang S, Wu YF, An N., et al. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Clin. Ther. 26(2), 257-270 (2004
93. Ghiadoni L, Magagna A, Kardasz I., et al. Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am. J. Hypertens. 22(5), 506-512 (2009
94. Asmar RG, London GB, O'Rourke ME., et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 38(4), 922-926 (2001
95. Dahlof B, Gosse P, Gueret P., et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J. Hypertens. 23(11), 2063-2070 (2005
96. De Luca N, Mallion JM, O'Rourke MF., et al. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am. J. Hypertens. 17(8), 660-667 (2004
97. Marre M, Puig JG, Kokot F., et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with Type 2 diabetes: the NESTOR Study. J. Hypertens. 22(8), 1613-1622 (2004
98. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting theirinterchangeability. Hypertension 43(1), 4-9 (2004
99. Kuo SW, Pei-Dee, , Hung YJ., et al. Effect of indapamide SR in the treatment of hypertensive patients with Type 2 diabetes. Am. J. Hypertens. 16(8), 623-628 (2008
100. Vinereanu D, Dulgheru R, Magda S., et al. The effect of Indapamide versus Hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial. Am. Heart J. 168(4), 446-456 (2014